Literature DB >> 19132495

Helical tomotherapy for total lymphoid irradiation.

Kathryn W McCutchen1, John M Watkins, Paul Eberts, Lacy E Terwilliger, Michael S Ashenafi, Joseph M Jenrette.   

Abstract

Total lymphoid irradiation is employed in the preparative regimens for allogeneic bone marrow and solid organ transplantation, solid organ transplant rejection, and chronic graft-versus-host disease. Linear accelerator-based radiotherapy, typically involving opposed anteroposterior and posteroanterior beams, has been commonly used; however, extended source-to-skin patient setup and/or field matching are required, and all organs within the beam coverage receive the entire prescribed dose. Megavoltage helical tomotherapy represents a technological advance in terms of both treatment delivery and patient positioning. The continuously rotating multileaf collimated fan beam allows highly conformal coverage of complex target geometries, in turn allowing avoidance of radiosensitive adjacent organs. In addition, the megavoltage computed tomographic scans allow potentially more accurate, targetbased setup verification. The present case report describes tomotherapy-based total lymphoid irradiation in an adult patient with late-onset cardiac transplant rejection. Treatment planning allowed dose minimization to the spinal cord, kidneys, intestinal compartment, and lungs. The patient tolerated treatment well without acute adverse effects, and he is now in early follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19132495     DOI: 10.1007/s11604-008-0281-4

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  17 in total

1.  Short-course total lymphoid irradiation for refractory cardiac transplantation rejection.

Authors:  Tee Sin Lim; Gerry O'Driscoll; Jerry Freund; Vicki Peterson; Helen Hayes; Jonelle Heywood
Journal:  J Heart Lung Transplant       Date:  2007-11-26       Impact factor: 10.247

Review 2.  Challenges in the clinical application of advanced technologies to reduce radiation-associated normal tissue injury.

Authors:  Lawrence B Marks; Jinli Ma
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-01       Impact factor: 7.038

3.  Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts.

Authors:  V G Valentine; R C Robbins; J H Wehner; H R Patel; G J Berry; J Theodore
Journal:  Chest       Date:  1996-05       Impact factor: 9.410

4.  A randomized trial of tacrolimus (FK506) versus total lymphoid irradiation for the control of repetitive rejection after cardiac transplantation.

Authors:  A M Keogh; R H Arnold; P S Macdonald; R C Hawkins; G W Morgan; P M Spratt
Journal:  J Heart Lung Transplant       Date:  2001-12       Impact factor: 10.247

5.  Intermediate term results of total lymphoid irradiation for the treatment of non-specific graft dysfunction after heart transplantation.

Authors:  B P Madden; J Barros; L Backhouse; S Stamenkovic; D Tait; A Murday
Journal:  Eur J Cardiothorac Surg       Date:  1999-05       Impact factor: 4.191

6.  Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.

Authors:  H J Ross; L Gullestad; J Pak; S Slauson; H A Valantine; S A Hunt
Journal:  J Heart Lung Transplant       Date:  1997-02       Impact factor: 10.247

7.  Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection.

Authors:  S L Wolden; D J Tate; S A Hunt; S Strober; R T Hoppe
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-12-01       Impact factor: 7.038

8.  Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up.

Authors:  E Gluckman; G Socie; A Devergie; H Bourdeau-Esperou; R Traineau; J M Cosset
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

9.  Single-field total lymphoid irradiation in the treatment of refractory rejection after heart transplantation.

Authors:  G D Trachiotis; T S Johnston; J D Vega; I R Crocker; N Chesnut; J F Lutz; A L Smith; K R Kanter
Journal:  J Heart Lung Transplant       Date:  1998-11       Impact factor: 10.247

10.  Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.

Authors:  Frank Heinzelmann; Peter J Lang; Hellmut Ottinger; Christoph Faul; Wolfgang Bethge; Rupert Handgretinger; Michael Bamberg; Claus Belka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-14       Impact factor: 7.038

View more
  5 in total

1.  Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties.

Authors:  Youlia M Kirova; Cyrus Chargari
Journal:  World J Radiol       Date:  2011-03-28

2.  Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.

Authors:  Berrin Pehlivan; Erkan Topkan; Cem Onal; Gul Nihal Nursal; Oznur Yuksel; Yemliha Dolek; Melek Nur Yavuz; Ali Aydin Yavuz
Journal:  Radiat Oncol       Date:  2009-09-16       Impact factor: 3.481

3.  Tomotherapy Applied Total Lymphoid Irradiation and Allogeneic Hematopoietic Cell Transplantation Generates Mixed Chimerism in the Rhesus Macaque Model.

Authors:  Lisa Forrest; John Fechner; Jennifer Post; Nathaniel Van Asselt; Kevin Kvasnica; Lynn D Haynes; Jenny Coonen; Kevin Brunner; W John Haynes; Christopher Little; William J Burlingham; Peiman Hematti; Samuel Strober; Dixon B Kaufman
Journal:  Radiat Res       Date:  2021-12-01       Impact factor: 2.841

Review 4.  The role of radiotherapy in Hodgkin's lymphoma: what has been achieved during the last 50 years?

Authors:  Magdalena Witkowska; Agata Majchrzak; Piotr Smolewski
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

5.  First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies.

Authors:  Darren Zuro; Srideshikan Sargur Madabushi; Jamison Brooks; Bihong T Chen; Janagama Goud; Amandeep Salhotra; Joo Y Song; Liliana Echavarria Parra; Antonio Pierini; James F Sanchez; Anthony Stein; Monzr Al Malki; Marcin Kortylewski; Jeffrey Y C Wong; Parham Alaei; Jerry Froelich; Guy Storme; Susanta K Hui
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-06-11       Impact factor: 7.038

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.